|Bid||37.38 x 1800|
|Ask||37.47 x 800|
|Day's Range||36.74 - 38.31|
|52 Week Range||27.02 - 125.00|
|Beta (5Y Monthly)||1.85|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 23, 2021 - Mar 01, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||56.39|
NEW YORK, NY / ACCESSWIRE / November 28, 2020 / Pomerantz LLP announces that a class action lawsuit has been filed against Intercept Pharmaceuticals, Inc.
LOS ANGELES, CA / ACCESSWIRE / November 27, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Intercept Pharmaceuticals, Inc.
NEW YORK, NY / ACCESSWIRE / November 27, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies.